Elanco Animal Health Inc (ELAT)
NYSE: ELAT
· Real-Time Price · USD
21.32
0.22 (1.04%)
At close: Jan 31, 2023, 10:00 PM
Elanco Animal Health Inc Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cattle Revenue | 268M | 272M | 754M | 253M | 249M | 242M | 210M | 248M | 469M | 227M | 248M | 17M | 15M | 21M | 27M | 19M | 64.1M | 16.1M |
Cattle Revenue Growth | -1.47% | -63.93% | +198.02% | +1.61% | +2.89% | +15.24% | -15.32% | -47.12% | +106.61% | -8.47% | +1358.82% | +13.33% | -28.57% | -22.22% | +42.11% | -70.36% | +298.14% | n/a |
Contract Manufacturing Revenue | 15M | 12M | 32M | 14M | 9M | 12M | 12M | 9M | 30M | 12M | 12M | 569M | 604M | 583M | 567M | 578M | n/a | n/a |
Contract Manufacturing Revenue Growth | +25.00% | -62.50% | +128.57% | +55.56% | -25.00% | 0.00% | +33.33% | -70.00% | +150.00% | 0.00% | -97.89% | -5.79% | +3.60% | +2.82% | -1.90% | n/a | n/a | n/a |
Farm Animal Revenue | 583M | 546M | 1.72B | 530M | 610M | 561M | 527M | 573M | 1.12B | 545M | 553M | 639M | 494M | 527M | 685M | 645M | n/a | n/a |
Farm Animal Revenue Growth | +6.78% | -68.26% | +224.53% | -13.11% | +8.73% | +6.45% | -8.03% | -48.88% | +105.69% | -1.45% | -13.46% | +29.35% | -6.26% | -23.07% | +6.20% | n/a | n/a | n/a |
Pet Health Revenue | 643M | 635M | 1.66B | 486M | 416M | 495M | 518M | 675M | 1.05B | 471M | 612M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pet Health Revenue Growth | +1.26% | -61.68% | +240.95% | +16.83% | -15.96% | -4.44% | -23.26% | -36.02% | +123.99% | -23.04% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Poultry Revenue | 215M | 189M | 608M | 188M | 220M | 184M | 178M | 183M | 366M | 176M | 174M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Poultry Revenue Growth | +13.76% | -68.91% | +223.40% | -14.55% | +19.57% | +3.37% | -2.73% | -50.00% | +107.95% | +1.15% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Swine Revenue | 100M | 85M | 278M | 88M | 98M | 93M | 89M | 102M | 200M | 95M | 89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Swine Revenue Growth | +17.65% | -69.42% | +215.91% | -10.20% | +5.38% | +4.49% | -12.75% | -49.00% | +110.53% | +6.74% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-Us Revenue | 648M | 639M | 1.86B | 543M | 574M | 589M | 557M | 714M | 1.25B | 553M | 638M | 703M | 610M | 624M | 698M | 709M | 633.6M | 468.1M | 338.2M | 357.8M | 383.1M | 386.6M | 347.2M | 1.2B | 378.9M |
Non-Us Revenue Growth | +1.41% | -65.65% | +242.54% | -5.40% | -2.55% | +5.75% | -21.99% | -43.11% | +126.94% | -13.32% | -9.25% | +15.25% | -2.24% | -10.60% | -1.55% | +11.90% | +35.36% | +38.41% | -5.48% | -6.60% | -0.91% | +11.35% | -71.18% | +217.95% | n/a |
United States Revenue | 593M | 554M | 1.55B | 487M | 461M | 479M | 500M | 543M | 951M | 475M | 539M | 522M | 503M | 507M | 581M | 533M | 506.1M | 421.5M | 248.1M | 299.9M | 388.2M | 395M | 383.9M | 1.1B | 382.2M |
United States Revenue Growth | +7.04% | -64.23% | +218.07% | +5.64% | -3.76% | -4.20% | -7.92% | -42.90% | +100.21% | -11.87% | +3.26% | +3.78% | -0.79% | -12.74% | +9.01% | +5.32% | +20.07% | +69.89% | -17.27% | -22.75% | -1.72% | +2.89% | -65.13% | +188.07% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 400M | 341M | 321M | 323M | 313M | 353M | 327M | 303M | 298M | 343M | 320M | 329M | 342M | 385M | 348M | 985.1M | 277.7M | 211.8M | 233.6M | 237.3M | 243M | 250.2M | 230.1M | 235.2M | 227.7M | 240.5M | 229.2M | 257M | 246.3M |
Selling, General, and Administrative Revenue Growth | +17.30% | +6.23% | -0.62% | +3.19% | -11.33% | +7.95% | +7.92% | +1.68% | -13.12% | +7.19% | -2.74% | -3.80% | -11.17% | +10.63% | -64.67% | +254.74% | +31.11% | -9.33% | -1.56% | -2.35% | -2.88% | +8.74% | -2.17% | +3.29% | -5.32% | +4.93% | -10.82% | +4.34% | n/a |
Research and Development Revenue | 92M | 94M | 96M | 87M | 86M | 81M | 81M | 80M | 78M | 82M | 81M | 92M | 94M | 94M | 89M | 112.7M | 88.1M | 59.4M | 66.8M | 67.3M | 69.9M | 68.8M | 64.1M | 61.1M | 58.9M | 61.4M | 65.2M | 62M | 61.9M |
Research and Development Revenue Growth | -2.13% | -2.08% | +10.34% | +1.16% | +6.17% | 0.00% | +1.25% | +2.56% | -4.88% | +1.23% | -11.96% | -2.13% | 0.00% | +5.62% | -21.03% | +27.92% | +48.32% | -11.08% | -0.74% | -3.72% | +1.60% | +7.33% | +4.91% | +3.74% | -4.07% | -5.83% | +5.16% | +0.16% | n/a |